Evanesc Therapeutics

Evanesc Therapeutics is a health care startup based in the United States, aiming to transform the treatment of neurological diseases with their groundbreaking EvaPermea technology. This patented medical device utilizes low power RF electric fields to temporarily and non-invasively open the blood-brain barrier (BBB), enabling the use of existing or new drugs in treating various neurological disorders and Central Nervous System (CNS) diseases. The potential applications of EvaPermea span across conditions such as Alzheimer's and Parkinson's disease, brain cancer, and brain metastases. The innovative approach of Evanesc Therapeutics holds promise in addressing critical unmet medical needs in the field of neurological health.